(Q39513393)

12 September 2017

Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (English)

1 reference

12 September 2017

Lars L Gustafsson

4

0 references

author name string

Vanda Markovic-Pekovic

series ordinal

1

1 reference

12 September 2017

Ranko Skrbić

series ordinal

2

1 reference

12 September 2017

Brian Godman

series ordinal

3

1 reference

12 September 2017

1 October 2012

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

12 September 2017

1 reference

12 September 2017

12

1 reference

12 September 2017

661-671

1 reference

12 September 2017

5

1 reference

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

12 September 2017

1 reference

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

21 January 2018

1 reference

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

21 January 2018

1 reference

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

21 January 2018

1 reference

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

21 January 2018

1 reference

Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs

21 January 2018

1 reference

Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina

21 January 2018

1 reference

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences

21 January 2018

1 reference

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications

21 January 2018

1 reference

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future

21 January 2018

1 reference

Switching statins in Norway after new reimbursement policy: a nationwide prescription study

21 January 2018

1 reference

Potential savings without compromising the quality of care

21 January 2018

1 reference

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.

21 January 2018

1 reference

Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries

21 January 2018

1 reference

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

21 January 2018

1 reference

Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines

21 January 2018

1 reference

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

21 January 2018

1 reference

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

21 January 2018

1 reference

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.12.48

1 reference

release_rmjzfwspuzdfhejyuqng33iejy

12 September 2017

0 references

1 reference